An observational study in Esophageal Neoplasm and Laryngeal Neoplasms, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-11.
Sponsored by University Hospital, Lille · Observational
The incidence of cancer in France has increased by +135% to reach nearly 400,000 new cases in 2018. The ten-year cancer control strategy 2021-2030 and the health innovation plan have defined strategic axes. Almost all of these axes are addressed in our project. Firstly, the main objective of our study is to improve the quality of life of patients. Secondly, pharyngolaryngeal and oesophageal cancers are among the cancers with a poor prognosis in adults. Thirdly, the project provides access to personalised supportive care for all patients at all times. Finally, the secondary objectives of this study are the prevention of post-operative complications (infectious, thrombo-embolic, pain...).
1,593 studies on the registry are indexed under Esophageal Neoplasms; 461 are open to participants now.
This study's enrollment of 30 is below the median of 200 across 341 observational studies indexed under Esophageal Neoplasms.
Browse Esophageal Neoplasms studies →University Hospital, Lille is the lead sponsor of 625 studies on the registry; 141 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients hospitalized for surgical management of esophageal or laryngeal cancer in Lille University Hospital
Exclusion Criteria:
The digital platform consists of 84 exercise sessions of progressive intensity. Each day, the tool offers 8 exercise sessions of about 5 to 10 minutes each, spaced out over an hour. One session can represent several exercises. The patient is asked to perform them daily.
Acceptability rate
Realization of the ratio between the number of inclusion proposals and the number of accepted inclusions.
Time frame: At 1 year
Adherence to exercise intervention program: Number of login
Time frame: Discharge from hospital if it occurs before 30 days or at Day 30
Adherence to exercise intervention program: Number of exercises completed
Time frame: Discharge from hospital if it occurs before 30 days or at Day 30
Adherence to exercise intervention program: type of exercises completed
Time frame: Discharge from hospital if it occurs before 30 days or at Day 30
Adherence to exercise intervention program: retention rate
Time frame: Discharge from hospital if it occurs before 30 days or at Day 30
Satisfaction by the System Usability Scale
Time frame: Discharge from hospital if it occurs before 30 days or at Day 30
Classification de Clavien-Dindo
Evaluation of the incidence of postoperative complications based on the Clavien-Dindo classification grade II
Time frame: At day 30
Visual Analogue Scale
Measure the pain in the scale from 0 to 10
Time frame: Before and after each activity
Instant Well-Being Evaluation (IWBE)
It consists of a graduated scale: the patient must position a cursor, the position on the left corresponding to "I feel very well" and the position on the right to "I do not feel well". The patient is guided by a pictogram (happy, neutral or sad face)
Time frame: Baseline, Discharge from hospital if it occurs before 30 days and at Day 30
Warwick-Edinburgh Mental Wellbeing Scales
The well-being and theu quality of life will be assessed using the Warwick-Edinburgh Mental Wellbeing Scales Each item is scored on a range from 1 to 5. The total score will be between 14 and 70, with lower scores indicating poor wellbeing, and higher scores indicating greater wellbeing. Very low wellbeing is defined as a score of ≤ 45. A substantial decrease in wellbeing is a decrease by 5 or more points.
Time frame: Baseline, Discharge from hospital if it occurs before 30 days and at Day 30
EuroQuol 5 Dimensions (EQ-5D-5L)
The quality of life will be assessed using the EuroQuol 5 Dimensions The EQ-5D-5L questionnaire will be used to estimate the impact on subjects' health-related quality of life and provides a description of subjects' problems by dimensions (descriptive system), a score for overall self-rated health (visual analogue scale \[VAS\]) as well as an index score (EQ-5D-5L index). EQ-5D index score range: 0 to 1 and EQ-5D-VAS: range 0 to 100. A higher score indicates better self reported health status.
Time frame: Baseline, Discharge from hospital if it occurs before 30 days and at Day 30
European Organisation for Research and Treatment of Cancer - Quality of Life Questionnaires (EORTC-QLQ-C30)
The quality of life will be assessed using the EORTC-QLQ-C30 The Quality of life questionnaire (QLQ-C30) contains 29 items dealing with fatigue, pain, nausea and vomiting, general condition and social, emotional and cognitive functions. It is currently used in many clinical trials in oncology
Time frame: Baseline, Discharge from hospital if it occurs before 30 days and at Day 30
This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Lille